Abstract
Background and aims
Endoscopic placement of enteral self-expandable metallic stents is an alternative to surgical gastrojejunostomy (GJ) for palliation of malignant gastric outlet obstruction (GOO). Factors associated with clinical outcomes are not known. The aims of this study are to compare the overall complication rate and effectiveness (duration of oral intake) between endoscopic stenting (ES) and GJ in patients with GOO and identify predictors of clinical outcomes.
Patients and methods
This was a retrospective cohort study at a single tertiary academic center. Patients who underwent ES or GJ for treatment of GOO between 1/2001 and 12/2010 were identified using an institutional claims database. The electronic medical records for each patient were reviewed. Univariate and multivariate logistic regression analyses were performed to study the association of treatment outcomes with patient factors and cancer therapy.
Results
120 patients had ES while 227 had GJ. Technical success was higher for GJ (99 vs. 96 %, p = 0.004). Complication rates were higher in the GJ group (22.10 vs. 11.66 %, p = 0.02). Reintervention was more common with ES [adjusted odds ratio (OR) 9.18, p < 0.0001]. Mean length of hospital stay (LOHS) was shorter (adjusted p = 0.005) in the ES compared with the GJ group. However, mean hospital charges, including reinterventions, were greater in the ES group (US $34,250 vs. US $27,599, p = 0.03). ES and GJ had comparable reintervention-free time in patients who had reintervention (88 vs. 106 days, respectively, p = 0.79). Chemotherapy [adjusted hazard ratio (HR) 3 > 0.57, p = 0.04] and radiation therapy (adjusted HR 0.35, p = 0.03) were associated with significantly longer duration of oral intake after ES or GJ.
Conclusion
ES is associated with fewer complications, shorter LOHS, but higher reintervention rates and overall charges.
Similar content being viewed by others
References
Lillemoe KD, Cameron JL, Hardacre JM, Sohn TA, Sauter PK, Coleman J, Pitt HA, Yeo CJ (1999) Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 230:322–328 discussion 328–330
van Heek NT, van Geenen RC, Busch OR, Gouma DJ (2002) Palliative treatment in “peri”-pancreatic carcinoma: stenting or surgical therapy? Acta Gastroenterol Belg 65:171–175
Warshaw AL, Fernandez-del Castillo C (1992) Pancreatic carcinoma. N Engl J Med 326:455–465
Mittal A, Windsor J, Woodfield J, Casey P, Lane M (2004) Matched study of three methods for palliation of malignant pyloroduodenal obstruction. Br J Surg 91:205–209
Johnsson E, Thune A, Liedman B (2004) Palliation of malignant gastroduodenal obstruction with open surgical bypass or endoscopic stenting: clinical outcome and health economic evaluation. World J Surg 28:812–817
Maetani I, Akatsuka S, Ikeda M, Tada T, Ukita T, Nakamura Y, Nagao J, Sakai Y (2005) Self-expandable metallic stent placement for palliation in gastric outlet obstructions caused by gastric cancer: a comparison with surgical gastrojejunostomy. J Gastroenterol 40:932–937
Del Piano M, Ballare M, Montino F, Todesco A, Orsello M, Magnani C, Garello E (2005) Endoscopy or surgery for malignant GI outlet obstruction? Gastrointest Endosc 61:421–426
Mehta S, Hindmarsh A, Cheong E, Cockburn J, Saada J, Tighe R, Lewis MP, Rhodes M (2006) Prospective randomized trial of laparoscopic gastrojejunostomy versus duodenal stenting for malignant gastric outflow obstruction. Surg Endosc 20:239–242
Watanapa P, Williamson RC (1992) Surgical palliation for pancreatic cancer: developments during the past two decades. Br J Surg 79:8–20
van der Schelling GP, van den Bosch RP, Klinkenbij JH, Mulder PG, Jeekel J (1993) Is there a place for gastroenterostomy in patients with advanced cancer of the head of the pancreas? World J Surg 17:128–132 discussion 132–123
Doberneck RC, Berndt GA (1987) Delayed gastric emptying after palliative gastrojejunostomy for carcinoma of the pancreas. Arch Surg 122:827–829
Adler DG, Baron TH (2002) Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients. Am J Gastroenterol 97:72–78
Dumas R, Demarquay JF, Caroli-Bosc FX, Paolini O, Guenenna D, Peten EP, Delmont JP, Rampal P (2000) Palliative endoscopic treatment of malignant duodenal stenosis by metal prosthesis. Gastroenterol Clin Biol 24:714–718
Kim JH, Yoo BM, Lee KJ, Hahm KB, Cho SW, Park JJ, Kim SS, Park HC (2001) Self-expanding coil stent with a long delivery system for palliation of unresectable malignant gastric outlet obstruction: a prospective study. Endoscopy 33:838–842
Maetani I, Tada T, Shimura J, Ukita T, Inoue H, Igarashi Y, Hoshi H, Sakai Y (2002) Technical modifications and strategies for stenting gastric outlet strictures using esophageal endoprostheses. Endoscopy 34:402–406
Nassif T, Prat F, Meduri B, Fritsch J, Choury AD, Dumont JL, Auroux J, Desaint B, Boboc B, Ponsot P, Cervoni JP (2003) Endoscopic palliation of malignant gastric outlet obstruction using self-expandable metallic stents: results of a multicenter study. Endoscopy 35:483–489
van Hooft JE, Uitdehaag MJ, Bruno MJ, Timmer R, Siersema PD, Dijkgraaf MG, Fockens P (2009) Efficacy and safety of the new WallFlex enteral stent in palliative treatment of malignant gastric outlet obstruction (DUOFLEX study): a prospective multicenter study. Gastrointest Endosc 69:1059–1066
Lindsay JO, Andreyev HJ, Vlavianos P, Westaby D (2004) Self-expanding metal stents for the palliation of malignant gastroduodenal obstruction in patients unsuitable for surgical bypass. Aliment Pharmacol Ther 19:901–905
Telford JJ, Carr-Locke DL, Baron TH, Tringali A, Parsons WG, Gabbrielli A, Costamagna G (2004) Palliation of patients with malignant gastric outlet obstruction with the enteral Wallstent: outcomes from a multicenter study. Gastrointest Endosc 60:916–920
Dormann A, Meisner S, Verin N, Wenk Lang A (2004) Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness. Endoscopy 36:543–550
Tierney W, Chuttani R, Croffie J, DiSario J, Liu J, Mishkin DS, Shah R, Somogyi L, Petersen BT (2006) Enteral stents. Gastrointest Endosc 63:920–926
Wong YT, Brams DM, Munson L, Sanders L, Heiss F, Chase M, Birkett DH (2002) Gastric outlet obstruction secondary to pancreatic cancer: surgical vs endoscopic palliation. Surg Endosc 16:310–312
Yim HB, Jacobson BC, Saltzman JR, Johannes RS, Bounds BC, Lee JH, Shields SJ, Ruymann FW, Van Dam J, Carr-Locke DL (2001) Clinical outcome of the use of enteral stents for palliation of patients with malignant upper GI obstruction. Gastrointest Endosc 53:329–332
Maetani I, Tada T, Ukita T, Inoue H, Sakai Y, Nagao J (2004) Comparison of duodenal stent placement with surgical gastrojejunostomy for palliation in patients with duodenal obstructions caused by pancreaticobiliary malignancies. Endoscopy 36:73–78
Fiori E, Lamazza A, Volpino P, Burza A, Paparelli C, Cavallaro G, Schillaci A, Cangemi V (2004) Palliative management of malignant antro-pyloric strictures. Gastroenterostomy versus endoscopic stenting. a randomized prospective trial. Anticancer Res 24:269–271
Jeurnink SM, Steyerberg EW, van Hooft JE, van Eijck CH, Schwartz MP, Vleggaar FP, Kuipers EJ, Siersema PD (2010) Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc 71:490–499
Ly J, O’Grady G, Mittal A, Plank L, Windsor JA (2010) A systematic review of methods to palliate malignant gastric outlet obstruction. Surg Endosc 24:290–297
Baron TH, Harewood GC (2003) Enteral self-expandable stents. Gastrointest Endosc 58:421–433
Mendelsohn RB, Gerdes H, Markowitz AJ, DiMaio CJ, Schattner MA (2011) Carcinomatosis is not a contraindication to enteral stenting in selected patients with malignant gastric outlet obstruction. Gastrointest Endosc 73:1135–1140
Kim JH, Song HY, Shin JH, Choi E, Kim TW, Jung HY, Lee GH, Lee SK, Kim MH, Ryu MH, Kang YK, Kim BS, Yook JH (2007) Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: prospective evaluation of results and factors influencing outcome in 213 patients. Gastrointest Endosc 66:256–264
Im JP, Kang JM, Kim SG, Kim JS, Jung HC, Song IS (2008) Clinical outcomes and patency of self-expanding metal stents in patients with malignant upper gastrointestinal obstruction. Dig Dis Sci 53:938–945
Disclosures
Mouen A. Khashab is a consultant for Boston Scientific. Patrick Okolo is a consultant for Boston Scientific. Anthony Kalloo is a founding member, equity holder, and consultant for Apollo Endosurgery. Ahmad S. Alawad, Eun Ji Shin, Katherine Kim, Nicolas Bourdel, Vikesh K. Singh, Anne Marie Lennon, Susan Hutfless, Reem Z. Sharaiha, Stuart Amateau, Martin A. Makary, Christopher Wolfgang, and Marcia Irene Canto have no conflicts of interest or financial ties to disclose.
Author information
Authors and Affiliations
Corresponding author
Additional information
Mouen Khashab and Ahmad S. Alawad contributed equally to this work.
Rights and permissions
About this article
Cite this article
Khashab, M., Alawad, A.S., Shin, E.J. et al. Enteral stenting versus gastrojejunostomy for palliation of malignant gastric outlet obstruction. Surg Endosc 27, 2068–2075 (2013). https://doi.org/10.1007/s00464-012-2712-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-012-2712-7